HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Low-dose oral pulse methotrexate as monotherapy in elderly patients with bullous pemphigoid.

AbstractBACKGROUND:
Prednisone alone or in combination with an immunosuppressive drug is usually effective in controlling bullous pemphigoid. However, corticosteroids often cause potentially hazardous side effects, especially in elderly patients.
OBJECTIVE:
Our purpose was to evaluate low-dose treatment with methotrexate in elderly patients with generalized bullous pemphigoid.
METHODS:
Oral methotrexate, at an initial dosage of 5 mg/wk, was given to 11 consecutive patients older than 70 years of age who were not responding to potent topical steroids. If the response was insufficient, the methotrexate dose was increased by 2.5 mg/wk to a maximum of 12.5 mg/wk.
RESULTS:
All patients responded with a marked and rapid decrease in disease activity. The disease was controlled in the majority of patients (8 of 11) with 5 to 7.5 mg of methotrexate per week. Three patients required a weekly dose of 10 to 12.5 mg. At 24 months of follow-up 7 patients were in complete remission and did not require methotrexate.
CONCLUSION:
Our study suggests that low-dose oral pulse methotrexate constitutes an effective therapeutic alternative in elderly patients with generalized bullous pemphigoid.
AuthorsJ D Heilborn, M Ståhle-Bäckdahl, F Albertioni, I Vassilaki, C Peterson, E Stephansson
JournalJournal of the American Academy of Dermatology (J Am Acad Dermatol) Vol. 40 Issue 5 Pt 1 Pg. 741-9 (May 1999) ISSN: 0190-9622 [Print] United States
PMID10321603 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Dermatologic Agents
  • Glucocorticoids
  • Immunosuppressive Agents
  • Prednisone
  • Methotrexate
Topics
  • Administration, Oral
  • Aged
  • Aged, 80 and over
  • Anemia (chemically induced)
  • Dermatologic Agents (administration & dosage, adverse effects, analysis, blood, therapeutic use)
  • Exudates and Transudates (chemistry)
  • Female
  • Follow-Up Studies
  • Glucocorticoids (administration & dosage, therapeutic use)
  • Humans
  • Immunosuppressive Agents (administration & dosage, adverse effects, analysis, blood, therapeutic use)
  • Male
  • Methotrexate (administration & dosage, adverse effects, analysis, blood, therapeutic use)
  • Pemphigoid, Bullous (drug therapy, pathology)
  • Prednisone (administration & dosage, therapeutic use)
  • Remission Induction
  • Safety

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: